Lymphopenia Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2014 Dec 16

PMID 25501097

Citations 41

Authors

Ji-Feng Feng

Jin-Shi Liu

Ying Huang

Affiliations

Soon will be listed here.

Abstract

Lymphopenia is a useful predictive factor in several cancers. The aim of this study was to determine the prognostic value of lymphopenia in patients with esophageal squamous cell carcinoma (ESCC).A retrospective analysis of 307 consecutive patients who had undergone esophagectomy for ESCC was conducted. In our study, a lymphocyte count (LC) of fewer than 1.0 Giga/L was defined as lymphopenia. Kaplan-Meier method was used to calculate the cancer-specific survival (CSS). Cox regression analyses were performed to evaluate the prognostic factors. Receiver operating characteristic (ROC) curve was also plotted to verify the accuracy of LC for CSS prediction.The mean LC was 1.55 ± 0.64 Giga/L (range 0.4-3.7 Giga/L). The incidence of lymphopenia (LC < 1.0 Giga/L) was 16.6% (51/307). Patients with lymphopenia (LC < 1.0 Giga/L) had a significantly shorter 5-year CSS (21.6% vs 43.8%, P = 0.004). On multivariate analysis, lymphopenia (LC < 1.0 Giga/L) was an independent prognostic factor in patients with ESCC (P = 0.013). Lymphopenia had a hazard ratio (HR) of 1.579 [95% confidence interval (CI): 1.100-2.265] for CSS. ROC curve demonstrated that lymphopenia (LC < 1.0 Giga/L) predicts survival with a sensitivity of 86.2% and a specificity of 27.2%. Lymphopenia (LC < 1.0 Giga/L) is still an independent predictive factor for long-term survival in patients with ESCC.

Citing Articles

Erythrocyte modified controlling nutritional status as a biomarker for predicting poor prognosis in post-surgery breast cancer patients.

Hu J, Dong J, Yang X, Ye Z, Hu G Sci Rep. 2025; 15(1):2071.

PMID: 39814814 PMC: 11736028. DOI: 10.1038/s41598-024-83729-1.

Enabling immune checkpoint blockade efficacy in T-lymphopenia by restoring CD8 T cell dynamics with IL-7 cytokine therapy.

Kang Y, Choi D, Moon D, Lee K, Oh Y, Yang J Front Immunol. 2025; 15:1477171.

PMID: 39763661 PMC: 11701376. DOI: 10.3389/fimmu.2024.1477171.

Baseline absolute lymphocyte count as a prognostic indicator in advanced or metastatic breast cancer: a systematic review and meta-analysis.

Xia G, Zhang Z, Jing S, Liu W Am J Transl Res. 2024; 16(9):5049-5062.

PMID: 39398610 PMC: 11470302. DOI: 10.62347/ZXWY3004.

A Novel Risk Factor for Para-Aortic Lymph Node Recurrence After Definite Pelvic Radiotherapy in Stage IIIB Cervical Cancer.

Zhang G, Wang C, Ma C, Miao L, He F, Fu C Technol Cancer Res Treat. 2022; 21:15330338221141541.

PMID: 36426576 PMC: 9703487. DOI: 10.1177/15330338221141541.

Is Lymphocyte C-Reactive Protein Ratio Useful for Predicting Survival in Patients with Non-Metastatic Soft Tissue Sarcoma?.

Nakamura T, Hagi T, Asanuma K, Sudo A Cancers (Basel). 2022; 14(21).

PMID: 36358634 PMC: 9655955. DOI: 10.3390/cancers14215214.

References

Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T . Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007; 25(10):1160-8. DOI: 10.1200/JCO.2005.04.7118. View

Yendamuri S, Swisher S, Correa A, Hofstetter W, Ajani J, Francis A . Esophageal tumor length is independently associated with long-term survival. Cancer. 2009; 115(3):508-16. DOI: 10.1002/cncr.24062. View

Hulscher J, van Sandick J, de Boer A, Wijnhoven B, Tijssen J, Fockens P . Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002; 347(21):1662-9. DOI: 10.1056/NEJMoa022343. View

Sefil F, Ulutas K, Dokuyucu R, Sumbul A, Yengil E, Yagiz A . Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus. J Int Med Res. 2014; 42(2):581-8. DOI: 10.1177/0300060513516944. View

Igaki H, Kato H, Tachimori Y, Sato H, Daiko H, Nakanishi Y . Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg. 2001; 19(6):887-93. DOI: 10.1016/s1010-7940(01)00701-1. View

Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi T, Yerian L . Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2011; 32(2):297-302. DOI: 10.1111/j.1478-3231.2011.02639.x. View

Thompson S, Ruszkiewicz A, Jamieson G, Esterman A, Watson D, Wijnhoven B . Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens. Ann Surg Oncol. 2008; 15(12):3447-58. DOI: 10.1245/s10434-008-0155-0. View

Donskov F . Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol. 2013; 23(3):200-7. DOI: 10.1016/j.semcancer.2013.02.001. View

Feng J, Huang Y, Lu W, Chen Q . Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor?. Langenbecks Arch Surg. 2013; 398(8):1115-22. DOI: 10.1007/s00423-013-1111-4. View

10.

Wijnhoven B, Tran K, Esterman A, Watson D, Tilanus H . An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007; 245(5):717-25. PMC: 1877056. DOI: 10.1097/01.sla.0000251703.35919.02. View

11.

Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J . Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 2013; 23(4):233-42. PMC: 3709543. DOI: 10.2188/jea.je20120162. View

12.

Waraich N, Rashid F, Jan A, Semararo D, Deb R, Leeder P . Vascular invasion is not a risk factor in oesophageal cancer recurrence. Int J Surg. 2010; 9(3):237-40. DOI: 10.1016/j.ijsu.2010.12.002. View

13.

Manuel M, Tredan O, Bachelot T, Clapisson G, Courtier A, Parmentier G . Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients. Oncoimmunology. 2012; 1(4):432-440. PMC: 3382902. DOI: 10.4161/onci.19545. View

14.

Mehrazin R, Uzzo R, Kutikov A, Ruth K, Tomaszewski J, Dulaimi E . Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. Urol Oncol. 2014; 33(9):388.e19-25. PMC: 4289664. DOI: 10.1016/j.urolonc.2014.06.004. View

15.

Rice T, Rusch V, Ishwaran H, Blackstone E . Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer. 2010; 116(16):3763-73. DOI: 10.1002/cncr.25146. View

16.

Saroha S, Uzzo R, Plimack E, Ruth K, Al-Saleem T . Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma. J Urol. 2012; 189(2):454-61. PMC: 3545104. DOI: 10.1016/j.juro.2012.09.166. View

17.

Feng J, Huang Y, Zhao Q . Tumor length in elderly patients with esophageal squamous cell carcinoma: is it a prognostic factor?. Ups J Med Sci. 2013; 118(3):145-52. PMC: 3713379. DOI: 10.3109/03009734.2013.792887. View

18.

Mariette C, Dahan L, Mornex F, Maillard E, Thomas P, Meunier B . Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol. 2014; 32(23):2416-22. DOI: 10.1200/JCO.2013.53.6532. View

19.

Rawat S, Kumar G, Kakria A, Sharma M, Chauhan D . Chemoradiotherapy in the management of locally advanced squamous cell carcinoma esophagus: is surgical resection required?. J Gastrointest Cancer. 2013; 44(3):277-84. DOI: 10.1007/s12029-013-9477-7. View

20.

Schwarz R, Smith D . Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg. 2007; 11(11):1384-93. DOI: 10.1007/s11605-007-0264-2. View